Agility Life Sciences
Generated by Meeveem AI
"Award winning CDMO turning badly behaved molecules into smart formulations for clinic and beyond."
Stapleford, Nottingham
•1 - 10 Employees
•Contract Research
About Agility Life Sciences
Agility Life Sciences is a formulation development CDMO specialising in transforming challenging small molecules and peptides into viable pharmaceutical products. The company tackles bioavailability barriers, solubility issues, permeability challenges, and stability problems that prevent drug candidates from progressing to clinical trials and commercial manufacture. Their Futureproof Formulations Fast approach serves pharmaceutical and biotech innovators by developing tailored formulations across multiple routes of administration. By considering the molecule's characteristics, client goals, study requirements, and target species, Agility creates formulations that accelerate timelines while reducing API requirements and costs.
10
Team Members
2012
Founded
Contract Research
Sector
Hybrid
Work Environment
Our Vision
A world where molecular challenges no longer limit the potential of life changing medicines to reach patients who need them.
Our Mission
At Agility Life Sciences, our mission is to accelerate pharmaceutical innovation by transforming challenging molecules into clinically viable formulations that enable rapid progression from discovery to patients.